Analysis suggests the need for pharma research into non-motor symptoms of Parkinson’s disease

Analysis of the online conversations among patients with Parkinson’s Disease suggests a need for pharmaceutical research to be targeted at treating the non-motor symptoms of the disease.

Cannabis Stocks Slide Again in May

As we described in a previous article, the Global Cannabis Stock Index fell sharply in March, plunging 15.2%, leaving it down 12.5% in the first quarter of

June 1, 2023

FDA greenlights label update to Gilead’s Biktarvy to include more data in pregnant people

The FDA on Friday approved a label update on Biktarvy, Gilead’s blockbuster HIV drug, to include more data on the drug’s safety and efficacy for

April 27, 2024

Health care execs mostly donate to Democrats, but avoid Trump and Harris

A vast majority of CEOs of major health systems and insurers are steering clear of donating their money to either Vice President Harris or former

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.